Description of antiviral treatment among adults hospitalized with influenza before and during the 2009 pandemic: United States, 2005-2009

Journal of Infectious Diseases

Volumn 204, Issue 12, 2011, Pages 1848-1856

  Doshi, Saumil ^a   Kamimoto, Laurie ^a   Finelli, Lyn ^a   Perez, Alejandro ^a   Reingold, Arthur ^c   Gershman, Ken ^d   Yousey Hindes, Kimberly ^e   Arnold, Kathryn ^b   Ryan, Patricia ^f   Lynfield, Ruth ^g   Morin, Craig ^g   Baumbach, Joan ^h   Hancock, Emily B ^h   Bennett, Nancy M ⁱ   Zansky, Shelley ^j   Thomas, Ann ^k   Schaffner, William ^l   Fry, Alicia M ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Georgia Emerging Infections Program   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d University of California ^*  (United States)

^e Colarado Department of Public Health and Environment ^*  (United States)

^f MARYLAND DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^g MINNESOTA DEPARTMENT OF HEALTH   (United States)

^h Minnesota Department of Health ^*  (Mexico)

ⁱ UNIVERSITY OF ROCHESTER   (United States)

^j NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^k OREGON PUBLIC HEALTH DIVISION   (United States)

^l VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; OSELTAMIVIR; PERAMIVIR; RIMANTADINE; ZANAMIVIR;

2009 H1N1 INFLUENZA; ADULT; AGED; ANTIVIRAL THERAPY; COHORT ANALYSIS; DISEASE SURVEILLANCE; DRUG USE; DRUG UTILIZATION; FEMALE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INFLUENZA A (H1N1); LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PREGNANCY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMANTADINE; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; GUIDELINE ADHERENCE; HOSPITALIZATION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; ODDS RATIO; OSELTAMIVIR; PANDEMICS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RIMANTADINE; UNITED STATES; YOUNG ADULT; ZANAMIVIR;

EID: 81055133027     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir648     Document Type: Review

References (32)

1. Cooper NJ, Sutton AJ, Abrams KR, Wailoo A, Turner D, Nicholson KG. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials. BMJ 2003; 326:1235.
2. Hanshaoworakul W, Simmerman JM, Narueponjirakul U, et al. Severe human influenza infections in Thailand: oseltamivir treatment and risk factors for fatal outcome. PLoS One 2009; 4:e6051.
3. Lee N, Chan PK, Choi KW, et al. Factors associated with early hospital discharge of adult influenza patients. Antivir Ther 2007; 12:501-8. (Pubitemid 47041148)
4. Lee N, Cockram CS, Chan PK, Hui DS, Choi KW, Sung JJ. Antiviral treatment for patients hospitalized with severe influenza infection may affect clinical outcomes. Clin Infect Dis 2008; 46:1323-4. (Pubitemid 351589924)
5. McGeer A, Green KA, Plevneshi A, et al. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis 2007; 45:1568-75. (Pubitemid 351411840)
6. Centers for Disease Control and Prevention. Updated interim recommendations for the use of antiviral medications in the treatment and prevention of influenza for the 2009-2010 season. http://www.cdc.gov/h1n1flu/ recommendations.htm. Published 7 December 2009 Accessed 1 January 2010.
7. Centers for Disease Control and Prevention. CDC issues interim recommendations for the use of influenza antiviral medications in the setting of oseltamivir resistance among circulating influenza A (H1N1) viruses, 2008-09 influenza season. http://emergency.cdc.gov/HAN/han00279.asp. Published 19 December 2008. Accessed 19 December 2008.
8. Centers for Disease Control and Prevention. 2008-2009 influenza season week 17 ending May 2, 2009. http://www.cdc.gov/flu/weekly/weeklyarchives2008- 2009/weekly17.htm. Updated 11 May 2009. Accessed 26 February 2011.
9. Birnkrant D, Cox E. The Emergency Use Authorization of peramivir for treatment of 2009 H1N1 influenza. N Engl J Med 2009; 361:2204-7.
10. Fry AM, Perez A, Finelli L. Use of intravenous neuraminidase inhibitors during the 2009 pandemic: results from population-based surveillance. JAMA 2011; 306:160-2.
11. Harper SA, Bradley JS, Englund JA, et al. Seasonal influenza in adults and children-diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2009; 48:1003-32.
12. Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009; 361:1935-44.
13. Louie JK, Acosta M, Winter K, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 2009; 302:1896-902.
14. Rasmussen SA, Jamieson DJ, Macfarlane K, Cragan JD, Williams J, Henderson Z. Pandemic influenza and pregnant women: summary of a meeting of experts. Am J Public Health 2009; 99(suppl 2):S248-54.
15. Creanga AA, Johnson TF, Graitcer SB, et al. Severity of 2009 pandemic influenza A (H1N1) virus infection in pregnant women. Obstet Gynecol 2010; 115:717-26.
16. Jamieson DJ, Honein MA, Rasmussen SA, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009; 374:451-8.
17. Siston AM, Rasmussen SA, Honein MA, et al. Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA 2010; 303:1517-25.
18. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep 2009; 58:521-4.
19. Update: novel influenza A (H1N1) virus infectionsdworldwide, May 6, 2009. MMWR Morb Mortal Wkly Rep 2009; 58:453-8.
20. Reed C, Angulo FJ, Swerdlow DL, et al. Estimates of the prevalence of pandemic (H1N1) 2009, United States, April-July 2009. Emerg Infect Dis 2009; 15:2004-7.
21. Cao B, Li XW, Mao Y, et al. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med 2009; 361:2507-17.
22. Farias JA, Fernandez A, Monteverde E, et al. Critically ill infants and children with influenza A (H1N1) in pediatric intensive care units in Argentina. Intensive Care Med 2010; 36:1015-22.
23. Kumar D, Michaels MG, Morris MI, et al. Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis 2010; 10:521-6.
24. Lee N, Chan PK, Hui DS, et al. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J Infect Dis 2009; 200:492-500.
25. Li IW, Hung IF, To KK, et al. The natural viral load profile of patients with pandemic 2009 influenza A(H1N1) and the effect of oseltamivir treatment. Chest 2010; 137:759-68.
26. Yang P, Deng Y, Pang X, et al. Severe, critical and fatal cases of 2009 H1N1 influenza in China. J Infect 2010; 61:277-83.
27. Yu H, Liao Q, Yuan Y, et al. Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China. BMJ 2010; 341:c4779.
28. Zarychanski R, Stuart TL, Kumar A, et al. Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection. CMAJ 2010; 182:257-64.
29. Dominguez-Cherit G, Lapinsky SE,Macias AE, et al. Critically ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 2009; 302:1880-7.
30. Centers for Disease Control and Prevention (CDC). Antiviral agents for the treatment and chemoprophylaxis of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR 2011; 60 (RR01):1-24. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6001a1.htm. .
31. Uyeki TM, Prasad R, Vukotich C, et al. Low sensitivity of rapid diagnostic test for influenza. Clin Infect Dis 2009; 48:e89-92.
32. Drexler JF, Helmer A, Kirberg H, et al. Poor clinical sensitivity of rapid antigen test for influenza A pandemic (H1N1) 2009 virus. Emerg Infect Dis 2009; 15:1662-4.